ANDA 77575, held by Chartwell Rx. Atorvastatin Calcium.
As of Nov 16, 2026, ANDA 77575 (Atorvastatin Calcium), held by Chartwell Rx, was first approved by FDA on May 29, 2012, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 29, 2012 | Original application | Approved |
| Atorvastatin CalciumEQ 10MG BASE · tablet;oral | Atorvastatin Calcium | Rx |
| Atorvastatin CalciumEQ 20MG BASE · tablet;oral | Atorvastatin Calcium | Rx |
| Atorvastatin CalciumEQ 40MG BASE · tablet;oral | Atorvastatin Calcium | Rx |
| Atorvastatin CalciumEQ 80MG BASE · tablet;oral | Atorvastatin Calcium | Rx |
| Jul 15, 2024 | Supplement 16Labeling · Standard review | Approved | None posted |
| Mar 30, 2023 | Supplement 15Labeling · Standard review | Approved | None posted |
| Mar 8, 2021 | Supplement 12Labeling · Standard review | Approved | None posted |
| Mar 8, 2021 | Supplement 13Labeling · Standard review | Approved | None posted |
| Mar 8, 2021 | Supplement 14Labeling · Standard review | Approved | None posted |
| Nov 4, 2019 | Supplement 9Labeling · Standard review | Approved | None posted |
| Nov 4, 2019 | Supplement 11Labeling · Standard review | Approved | None posted |
| Dec 7, 2018 | Supplement 10Labeling · Standard review | Approved | None posted |
| Oct 6, 2015 | Supplement 4Labeling · Standard review | Approved | None posted |
| Sep 23, 2014 | Supplement 3Labeling · Standard review | Approved | None posted |
| Dec 12, 2012 | Supplement 2Labeling · Standard review | Approved | None posted |
| May 29, 2012 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters